Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Hiroaki Ikezaki Last modified date:2019.12.09

Associate Professor / Department of Comprehensive General Internal Medicine
Faculty of Medical Sciences




E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
Academic Degree
Ph.D.(Dr. of Medical Science): Kyushu University Graduate School of Medical Sciences
Country of degree conferring institution (Overseas)
No
Field of Specialization
Atherosclerosis, Lipid Metabolism, Infectious Disease, Liver Disease
Total Priod of education and research career in the foreign country
02years06months
Outline Activities
Clinical Research: Investigating risk factors of atherosclerotic cardiovascular disease and malignant tumors in a prospective, observational, community-dwelling cohort study.

Clinical Activity: General Internal Medicine
Research
Research Interests
  • Epidemiological research for risk factors of Atherosclerotic Cardiovascular Diseases and Malignant Tumors
    keyword : Atherosclerotic Cardiovascular Diseases, Lipid Metabolism, Malignant Tumors
    2010.04.
Academic Activities
Papers
1. Ikezaki H, Fisher VA, Lim E, Ai M, Liu CT, Cupples LA, Nakajima K, Asztalos BF, Furusyo N, Schaefer EJ, Direct versus calculated low-density lipoprotein cholesterol and C reactive protein in cardiovascular disease risk assessment in the Framingham Offspring Study, Clinical Chemistry, 10.1373/clinchem.2019.304600, 65, 9, 1102-1114, 2019.09.
2. Ikezaki H, Furusyo N, Jacques PF, Shimizu M, Murata M, Schaefer EJ, Urita Y, Hayashi J, Higher dietary cholesterol and omega-3 fatty acid intakes are associated with a lower successful rate of Helicobacter pylori eradication therapy in Japan., American Journal of Clinical Nutrition, 10.3945/ajcn.116.144873, 106, 2, 581-588, 2017.08.
3. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N, Cardiovascular Disease Prevalence and Insulin Resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study., Journal of Clinical Lipidology, 10.1016/j.jacl.2017.01.014, 11, 2, 348-356, 2017.03.
4. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N, Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study., Scientific Reports, 10.1038/srep36725, 6, 36725, 2016.11.
5. Ikezaki H, Nomura H, Furusyo N, Ogawa E, Kajiwara E, Takahashi K, Kawano A, Maruyama T, Tanabe Y, Satoh T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group, Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular., Hepatology Research, 10.1111/hepr.12555, 46, 3, E174-E180, 2016.03.
6. Ikezaki H, Furusyo N, Hiramine S, Ura K, Mistumoto-Kaseida F, Takayama K, Shimizu M, Toyoda K, Ogawa E, Kainuma M, Murata M, Hayashi J, IL28B rs8099917 genotype and female sex contribute to the spontaneous clearance of hepatitis C: A Japanese cross-sectional study., Archives of Virology, 10.1007/s00705-015-2703-9, 161, 3, 641-648, 2016.03.
7. Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J, Glycated Albumin as a diagnostic tool for diabetes in a general Japanese population., Metabolism – Clinical and Experimental, 10.1016/j.metabol.2015.03.003, 64, 6, 698-705, 2015.06.
8. Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J, The utility of urinary myo-inositol as a marker of glucose intolerance., Diabetes Research and Clinical Practice, 10.1016/j.diabres.2013.11.018, 103, 1, 88-96, 2014.01.
9. Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ogawa E, Toyoda K, Taniai H, Kainuma M, Murata M, Hayashi J, Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis C., Journal of Infection and Chemotherapy, 10.1007/s10156-011-0249-7, 17, 6, 737-743, 2011.12.
Presentations
1. Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ, Small Dense Low Density Lipoprotein Cholesterol Level Predicts Carotid Intimal Medial Thickness Progression over 5 years, AHA Scientific Sessions 2019, 2019.11.
2. Ikezaki H, Lim E, Liu CT, Cupples LA, Nakajima K, Asztalos BF, Murata M, Furusyo N, Schaefer EJ, Small dense LDL cholesterol as a cardiovascular risk assessment; results from Framingham Offspring Study, AHA Scientific Sessions 2019, 2019.11.
3. Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ, Small Dense Low Density Lipoprotein Cholesterol Predict Carotid Intimal Medial Thickness Progression, Vascular Discovery Scientific Sessions 2019, 2019.05.
4. Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Murata M, Furusyo N, Asztalos BF, Schaefer EJ, Direct Lipoprotein Measurements and Cardiovascular Disease Risk Assessment in the Framingham Offspring Study, Vascular Discovery Scientific Sessions 2019, 2019.05.
5. Ikezaki H, Fisher VA, Liu Ct, Cupples LA, Nakajima K, Asztalos BF, Schaefer EJ, Low Density Lipoprotein Subfractions, Lipoprotein(a), and Cardiovascular Disease Risk Assessment in the Framingham Offspring Study, AHA Scientific Sessions 2018, 2018.11.
6. Ikezaki H, Yokota Y, Schaefer EJ, Horvath KV, Asztalos BF, Furusyo N, Lipoprotein(a) and Carotid Intimal Medial Thickness, ATVB/PVD 2017, 2017.05.
7. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N, Hyperinsulinemia and Cardiovascular Disease in Japan and the United States, AHA Scientific Session 2016, 2016.11.
8. Ikezaki H, Fisher VA, Cupples LA, Minagawa A, Ito Y, Schaefer EJ, Remnant Lipoprotein Cholesterol and Other Lipoprotein Levels in Coronary Heart Disease Cases and Controls: Results from the Framingham Offspring Study, 5th International Symposium on Chylomicrons in Diseases, 2016.11.
9. Ikezaki H, Furusyo N, Jacques PF, Murata M, Schaefer EJ, Urita Y, Hayashi J, Impact of food consumption on Helicobacter pylori eradication therapy: a Japanese community-based observational study, ID Week 2016, 2016.10.
10. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Yanhua Z, Liu CT, Jacques PF, Cupples LA, Furusyo N, Cardiovascular Disease Prevalence and Risk Factors in Japanese and American Populations, ATVB/PVD 2016, 2016.05.
11. Ikezaki H, Furusyo N, Hiramine S, Ogawa E, Murata M, Hayashi J, Natural human interferon-beta plus ribavirin treatment toleration by chronic hepatitis C patients with depression or thrombocytopenia, ID Week 2013, 2013.10.
Membership in Academic Society
  • American Heart Association, Council on Epidemiology and Prevention, and Arteriosclerosis, Thrombosis & Vascular Biology
  • The Japanese Society of Internal Medicine
  • The Japanese Society of Hepatology
  • The Japanese Association of Infectious Diseases
  • Japan Atherosclerosis Society
  • The Japan Geriatrics Society
  • The Japan Diabetes Society
  • The Japanese Society of Hospital General Medicine
  • The Japanese Society for Helicobacter Research
Awards
  • ATVB Council Travel Awards for Young Investigators, AHA Scientific Sessions 2018
  • Young Investigator Award, the Japanese Association for Infectious Diseases, West Japan Council
  • Encourage award in 10th Scientific Meeting, The Fukuoka Association of Medical Sciences
  • Research Grant in 2017, Kaibara Morikazu Medical Science Promotion Foundation
  • Research Grant in 2017, The Japanese Society of Hospital General Medicine
  • Society’s award in 2017, The Japanese Society of Hospital General Medicine
  • 27th Japan Heart Foundation / Bayer Yakuhin Research Grant Abroad
  • Chairman’s award in 6th Scientific Meeting, The Japanese Society of Hospital General Medicine